2/2 left

PFE stock verdict - Avoid

PFE
Pfizer, Inc.
AVOIDHealthcare
$26.79 Fundamentals below bar
$26.79
Heavy$30.13Buy$40.17Fair$50.21Exit$60.25
FUNDAMENTAL45
TECHNICAL90
TRUST SCORE
100High
confidence in this read — data completeness, earnings quality & coverage
Uptrend · EMA20 25.83 · EMA50 25.51 · EMA200 25.73 · RSI 64.8 · MACD above signal
PROS
  • Trades 47% below the model's fair value ($50.21)
  • Reasonable forward P/E of 9.3× on analyst estimates
  • Balance sheet holds net cash (cash exceeds total debt)
  • Converts 17% of revenue into free cash flow
  • High gross margin of 68% (3-yr avg)
CONS
  • Expensive on trailing earnings (P/E 35.5×)
  • Rich for its growth rate (PEG 3.6)
  • Company has a low return on equity of 4.9% (TTM)
  • Revenue declined 12.0%/yr on average over the last 3 years
  • TTM EPS fell 59.8% year-over-year
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
Operating cash flow is 151% of net income — profit is backed by real cash
Low accruals — reported profit tracks the cash actually generated
Receivables growing in line with sales
Analysis as of 2026-08-16 · price live, fundamentals from latest filings
Congress Trading — last 90 days
See what senators are buying and selling on PFE. Sign in to unlock.
Sign in to view

FAQ

Why is PFE rated Avoid?

PFE (Pfizer, Inc.) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. Trades 47% below the model's fair value ($50.21) and Reasonable forward P/E of 9.3× on analyst estimates

Is PFE overvalued right now?

PFE is trading at $26.79 versus an estimated fair value of $50.21. That puts the stock in avoid territory on this framework. Expensive on trailing earnings (P/E 35.5×) and Rich for its growth rate (PEG 3.6)

What should I watch before acting on PFE?

Watch the trust score of 100, the earnings-quality checks, and any red flags. Expensive on trailing earnings (P/E 35.5×) and Rich for its growth rate (PEG 3.6)

Analyze another